Financial Health Assessment: ALTRAD INTEGRITY SERVICES LIMITED

1. Financial Health Score: B+

Explanation: The patient exhibits excellent structural and compliance health, showing no signs of administrative distress. The company benefits from a robust corporate "immune system" through its parent companies. However, the grade is withheld from an 'A' due to the nominal share capital (£10), which suggests the entity operates as a lean subsidiary reliant on group funding, and the inherent volatility of its industry sector (oil and gas support). A full quantitative grade requires viewing the complete financial "bloodwork," which is currently pending in the latest filings.

2. Key Vital Signs

• Corporate Pulse (Company Status & Age): Strong. The company has been active for nearly 30 years (incorporated in 1995). In the corporate world, surviving for three decades—especially in the cyclical energy sector—is a sign of deep-rooted resilience.
• Compliance Temperature (Filing Status): Healthy. Both the annual accounts and the confirmation statement are up to date, with no overdue flags. This indicates a well-administered company with no symptoms of administrative neglect or impending regulatory issues.
• Genetic Lineage (Ownership & Control): Robust. The PSC register shows that Stork Technical Services (Holdings) Limited and Altrad Technical Services (Holdings) Limited each own more than 75% of the shares and voting rights. This provides the company with a strong corporate immune system, meaning it has deep-pocketed parent companies to call upon in times of financial distress.
• Organ Evolution (Corporate History): Adaptive. The company has evolved through several identities (from Rigblast Group to RBG, to Stork, and now Altrad). This is a classic medical history of a company that has grown through mergers and acquisitions, adapting its identity to reflect its current corporate parentage.
• Capital Nutrition (Share Capital): Anaemic (on paper). The issued share capital is only £10. While this looks alarming on the surface, it is a common structural feature for UK subsidiaries. It indicates the business is likely funded through inter-company loans from its parent entities rather than its own equity reserves.

3. Diagnosis

Based on the available clinical data, Altrad Integrity Services Limited is a structurally sound, mature entity operating as a subsidiary within a larger multinational group (the Altrad/Stork conglomerate). The recent name change in March 2025 signals a successful integration into the Altrad brand following past acquisitions.

The lack of publicly visible financial metrics (turnover, assets, liabilities) in this specific diagnostic snapshot means we cannot measure the company's profitability or liquidity directly. However, the absence of overdue filings, liquidation flags, or director disqualifications confirms there are no immediate symptoms of financial distress or corporate governance failure. The business operates in the oil and gas support sector, which is prone to severe cyclical "fevers" (boom and bust cycles tied to commodity prices), making the backing of its parent companies a vital lifeline during industry downturns.

4. Recommendations

• Conduct a Full Quantitative Blood Panel: To truly assess the financial wellness of this patient, the full filed accounts at Companies House must be reviewed. Specifically, examine the net current assets (working capital) and inter-company loan balances to ensure the parent group is not extracting excessive dividends or loading the subsidiary with unsustainable debt.
• Monitor Sector-Specific Risks: Operating in petroleum support services means the company's health is tied to oil and gas prices. Management should ensure cash flow reserves are sufficient to weather the inevitable industry downturns without relying entirely on parent company bailouts.
• Leadership Succession Planning: Note the recent/pending director resignation (John Anthony Meade Walsh). Ensure a smooth transition of responsibilities to maintain the current healthy administrative state and prevent any compliance "infections" from missed filing deadlines during the handover.